New Drug For Colorectal Cancer, Plus Standard
Ones, Improves Survival
TRENTON, New Jersey (AP) - In the biggest advance
against end- stage colorectal cancer in 40 years, researchers have found
that combining a new drug with the standard ones can more effectively slow
the cancer and prolong victims' lives slightly.